presentation to u k flight safety committee drug amp
play

Presentation to U.K. Flight Safety Committee Drug & Alcohol - PowerPoint PPT Presentation

Presentation to U.K. Flight Safety Committee Drug & Alcohol Testing 9 th March 2010 Bill Percy Agenda Introduction to Concateno Airline Experience Implementing a Policy Drug testing options Support Services Concateno Plc


  1. Presentation to U.K. Flight Safety Committee Drug & Alcohol Testing 9 th March 2010 Bill Percy

  2. Agenda  Introduction to Concateno  Airline Experience  Implementing a Policy  Drug testing options  Support Services

  3. Concateno Plc  The Leading Provider of Drug & Alcohol Testing Services  Highest levels of Accreditation and Quality Assurance  11 Million Drug Tests per annum  Over 8,000 Customers  Over 300 Staff  International Collection Network of over 500 officers  Public Limited Company (London AIM)  £50m Turnover (forecast ’08)

  4. Airline Experience  Emirates  VAA  BA  Qantas  Bmi  Ryan Air  My Travel  easyJet

  5. Implementing a Policy  Considerate Implementation  Managerial training packages  Employee Communication  Newsletters  Staff associations  Payslips  Notice boards  Education & awareness material

  6. Testing – the Options

  7. Breath  Lion SD400P alcometers  Evidential & legally defensible  Supported by breath test record  Collecting Officer accreditation  Quick & reliable

  8. Urine  3 – 4 day detection window (average)  high concentration of drug  large sample volume  Used in regulated industries  E.g. Rail, Maritime, Oil, Transport  Established cut off levels  Highly researched & accepted  2 stage process  Instant or BTL

  9. Oral fluid  12 hour – 24 hour day detection window  non invasive  collect single sample that is split – IDENTICAL  Avoids collection of 2 non-identical samples  No common cut off levels  2 stage process  Instant or BTL

  10. Hair  Long detection window (1 cm = 1 month)  Longer turn around time – labour intensive testing  Common workplace use  Pre-employment, Corroborative  Other uses  Medico-Legal

  11. The Testing process UKAS ISO 17025 Accreditation – QA & QC 1. PRIMARY SCREEN – IMMUNOASSAY Laboratory or  non-specific drug identification On-site test  identifies NEGATIVE specimens 2. GC(LC)/MS CONFIRMATION TEST (Gas (Liquid) Chromatography / Mass Spectrometry)  compound specific - ‘fingerprint’  quantitative results

  12. Medical Review Officer  Capability to provide MRO if required  Access to panel of independent MRO’s  Good working relationship with Toxicologists

  13. Quality Assurance  Laboratories - UKAS 17025 accreditation  Robust QA & QC schemes  Hair - SoHT, GTFCH  Urine - CAP, UK NEQAS, Link Up, Tackler Analytical  Oral fluids - Research Triangle International, UK NEQAS  External Proficiency schemes

  14. Random testing  Independence is important  Dedicated Programme Manager  Varying levels of support offered  Programme Managed  Programme Assisted  Day to Day contact & support

  15. Collection Teams  500 Collectors globally  150 Collectors in UK  UK Collectors directly employed, trained and audited  UKAS 17025 accredited for field breath testing

  16. Collection Services For Cause  Regional teams with overlapping cover  Team is paged that can give the fastest response  The ‘clock’ starts from the time agreed at the end of your call  > 98% within 2 hours  Average response time (2008) = 78 minutes  1637 Call outs in ‘06; > 2000 in ‘07

  17. Chain of Custody  1 of 3 steps in legally defensible testing  Input to CoC protocols through EWDTS  Collecting Officers trained & regularly audited  UKAS 17025 accredited for breath testing  Laboratory UKAS 17025 accredited  QA – range of initiatives  QC – exhaustive  Not one successfully challenged sample

  18. Management Reports  Wide range of data captured by LIMS  Agree content of standard reports  Ability to create non-standard, bespoke reports  Results reporting  Password protected PDF

  19. Thank You & Questions

Recommend


More recommend